However, two recent studies in ALCL identified downregulated miR-29 as an inducer of cell survival through targeting of induced myeloid leukemia cell differentiation protein (MCL-1) [88] and downregulated miR-16 as a driver of vascular endothelial growth factor expression in ALK+ disease [89]. This evidence concerns the gene ALK and anaplastic large cell lymphoma.